Mushrooms for Liver Health: Which Ones Work Best?

Several mushroom species show genuine promise for supporting liver health, but the honest picture is more complicated than supplement labels suggest. Reishi, cordyceps, and shiitake are among the most studied, with animal research consistently showing they can reduce liver fat accumulation, lower inflammation, and even slow the scarring process known as fibrosis. The catch is that nearly all the strong evidence comes from rodent studies and cell experiments, not large human trials. And in a twist that surprises many people, the single most-studied liver mushroom, reishi, has also been linked to liver injury in certain circumstances.

Reishi and Liver Fibrosis

Reishi (Ganoderma lucidum) has more published research on liver effects than any other medicinal mushroom. Much of the recent attention focuses on its polysaccharides and their ability to interfere with fibrosis, the progressive scarring that can eventually lead to cirrhosis. In mouse models, reishi polysaccharides significantly blocked the activation of hepatic stellate cells, the cells responsible for laying down scar tissue in the liver. The polysaccharides also reduced levels of collagen and suppressed a key signaling pathway involved in fibrosis progression.¹

A broad review of mushroom hepatoprotective research identified reishi as “indubitably the most widely studied species” for liver protection, noting that its extracts contain a rich mixture of terpenes, polysaccharides, and phenolic compounds that likely contribute to its effects.² That breadth of research is genuinely impressive. But as we will see later in this article, reishi also carries real safety concerns that anyone considering it should understand.

Cordyceps for Fatty Liver Disease

Cordyceps species, particularly through their active compound cordycepin, have generated some of the most specific liver research in the mushroom world. The focus has been on non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), conditions that affect a growing share of the global population.

In mice fed a high-fat diet, cordycepin reduced body weight and liver weight, lowered blood levels of liver enzymes (markers of liver damage), decreased triglycerides and LDL cholesterol, and raised HDL cholesterol. It also dampened the production of several inflammatory molecules in the liver.³ A separate study in mice with diet-induced NASH found that cordycepin reduced fat buildup in liver cells, decreased inflammatory cell infiltration, and reduced hepatic fibrosis in a dose-dependent manner, meaning higher doses produced stronger effects.⁴

A compound from the related species Ophiocordyceps sinensis, called cerevisterol, has also been investigated for anti-fibrotic properties. In lab studies, it inhibited the activation and proliferation of hepatic stellate cells and reduced expression of genes tied to excess scar-tissue formation.⁵ These findings suggest cordyceps species may target both the fat accumulation and the scarring stages of progressive liver disease, though again the evidence so far comes from animals and cells, not clinical trials.

Shiitake and Cholesterol Metabolism

Shiitake (Lentinus edodes) takes a somewhat different angle on liver health. Its standout compound is eritadenine, a naturally occurring molecule that influences how the liver processes cholesterol. In mice with high cholesterol, eritadenine and shiitake supplementation increased the activity of an enzyme that helps convert cholesterol to bile acids, one of the body’s main routes for clearing excess cholesterol. The treatment also visibly reduced fat deposits in liver tissue.⁶

Earlier rat studies confirmed that eritadenine significantly decreased blood levels of cholesterol and phospholipids, and altered the composition of fats in both blood and liver cell membranes.⁷ Shiitake’s relevance to liver health is therefore somewhat indirect: by helping clear lipids that would otherwise accumulate in liver cells, it may reduce the metabolic burden that leads to fatty liver disease over time. If you are someone who already eats shiitake regularly, this is a reasonable fringe benefit of a mushroom people enjoy for its taste.

Maitake and Oyster Mushrooms

Maitake (Grifola frondosa) and oyster mushrooms (Pleurotus ostreatus) both show lipid-lowering effects in animal models, with some overlap in how they work.

In rats fed a high-cholesterol diet, maitake supplementation consistently kept liver and blood lipid levels lower than those seen in the cholesterol-only control group. HDL cholesterol, the kind you want to keep up, stayed at baseline levels instead of dropping. The maitake-fed rats also had significantly lighter livers and less abdominal fat, suggesting the mushroom was curbing fat storage at the organ level.⁸

Oyster mushroom produced an even more dramatic effect in rats. At a dietary inclusion level of 5%, it reduced blood cholesterol by roughly 30 to 45% and liver cholesterol by about 25 to 30%. It also boosted levels of glutathione in the liver and increased the activity of catalase and glutathione peroxidase, two enzymes that protect cells from oxidative damage.⁹ Those antioxidant effects matter because oxidative stress is a major driver of liver cell damage in conditions from fatty liver disease to hepatitis.

Lesser-Known Species Worth Knowing About

A few mushrooms that rarely appear in mainstream wellness marketing have shown interesting hepatoprotective properties in research settings.

Poria cocos, a fungus used for centuries in traditional Chinese medicine, contains triterpene acids that inhibit bile acid uptake transporters in the liver and gut. In lab experiments, poria extract blocked these transporters at relatively low concentrations, and specific compounds like poricoic acid A were identified as competitive inhibitors.¹⁰ Disrupting bile acid transport could theoretically influence cholesterol clearance and protect against certain forms of bile-acid-mediated liver injury, though the practical implications for humans remain speculative.

Phellinus linteus, a hard bracket fungus sometimes called mesima, has been studied for protection against acetaminophen-induced liver damage. A polysaccharide extracted from its mycelium reduced the expression of an enzyme involved in processing acetaminophen into a toxic metabolite, and boosted phase II detoxification enzymes that help the liver neutralize harmful compounds.¹¹ This is a single animal study, so nobody should treat it as a green light to combine Phellinus supplements with high-dose painkillers. But it illustrates a different protective angle: modulating how the liver handles toxic metabolites rather than targeting lipid accumulation.

The morel mushroom (Morchella esculenta) is better known as a culinary delicacy than a medicinal mushroom, but its mycelium extract showed hepatoprotective activity in rats exposed to both carbon tetrachloride and ethanol. The extract reduced elevated liver enzymes in a dose-dependent fashion and restored depleted antioxidant levels in the liver.¹²

Ergothioneine and Broad Antioxidant Protection

One reason mushrooms as a category seem helpful for the liver is ergothioneine, an amino acid that mushrooms accumulate in unusually high concentrations. Ergothioneine is a potent antioxidant with a special affinity for tissues under oxidative stress. In rats exposed to a chemical that induces severe oxidative damage, supplementation with ergothioneine significantly preserved polyunsaturated fatty acids in the liver, protecting some by as much as 32%. It also reduced conjugated dienes (a marker of lipid damage) and conserved levels of both glutathione and alpha-tocopherol in liver and kidney tissue.¹³

Nearly all commonly eaten mushrooms contain meaningful amounts of ergothioneine. This means that even if you never touch a reishi or cordyceps supplement, simply eating mushrooms regularly may provide a baseline level of antioxidant support for the liver. Your body has a dedicated transporter for ergothioneine, which concentrates it preferentially in organs that face high oxidative loads, including the liver.

Combining Mushroom Species

Some researchers have explored whether blending compounds from different mushroom species produces stronger liver protection than any single species alone. A study combining polysaccharides from Cordyceps sinensis and Ganoderma atrum tested the mixture in mice with drug-induced liver injury. The combination outperformed individual polysaccharides in restoring antioxidant balance, reducing markers of inflammation, and suppressing a mitochondrial pathway tied to liver cell death.¹⁴

This is a single mouse study, so it is far from a prescription for stacking supplements. But the reasoning behind it is sound: different mushroom species tend to work through different mechanisms. One may be strongest at reducing fat accumulation while another excels at dampening inflammation or blocking stellate cell activation. In theory, combining them could cover more of the pathways involved in liver disease progression. Whether that theoretical advantage translates to meaningful benefit in humans is unknown.

Why So Few Human Trials Exist

If you have been reading carefully, you have probably noticed that every study mentioned so far used rodents or cell cultures. This is the central limitation of the entire mushroom-liver field, and it deserves direct acknowledgment rather than a footnote. The gap between what a purified compound does in a mouse liver and what a capsule of dried mushroom powder does in your body is enormous. Doses used in rodent studies are often far higher, relative to body weight, than anything a person would take. The extracts used are usually standardized to a specific active compound at a known concentration, while commercial supplements vary wildly in their actual content. And mice metabolize many substances differently than humans do.

None of this means the animal research is meaningless. It tells us which mushrooms contain compounds that interact with liver biology in potentially useful ways, and it helps identify the mechanisms behind those interactions. But when someone asks “which mushrooms work best for liver health,” the honest answer is that we know which ones show the strongest effects in animals. We do not yet have enough clinical data to rank them for humans.

When Mushrooms Hurt the Liver Instead

The same reishi mushroom that tops the list for laboratory liver research has also appeared in case reports of acute liver injury. In one documented case, a 47-year-old man developed significant acute hepatitis after consuming reishi mushroom powder alongside alcohol. His liver enzyme levels spiked dramatically, and he required treatment with N-acetylcysteine and intravenous fluids.¹⁵ The combination of an unregulated supplement and alcohol was identified as a likely contributor.

This is not an isolated report. The pattern that emerges from the case literature is that reishi supplements, particularly concentrated extracts or powders taken at high doses, can be hepatotoxic in certain individuals. Alcohol use, pre-existing liver conditions, and concurrent medication all seem to raise the risk. The irony is hard to miss: the mushroom most studied for protecting the liver can, under certain conditions, damage it.

Beyond species-specific toxicity, wild mushrooms can accumulate heavy metals from contaminated soil. A study analyzing wild edible mushrooms found that different species concentrated different metals at rates that raised health concerns, particularly for children, whose intake relative to body weight was estimated at roughly 1.5 times that of adults.¹⁶ For anyone foraging wild mushrooms or buying products sourced from wild-harvested fungi, this is a real consideration. Cultivated mushrooms grown on controlled substrates generally carry much lower contamination risk.

Practical Guidance for People Considering Mushroom Supplements

If you are thinking about adding a mushroom supplement for liver support, a few things are worth keeping in mind. First, the form of the supplement matters. Mushroom cell walls are made of chitin, which humans digest poorly. Hot-water extraction breaks down chitin and releases polysaccharides, while alcohol (ethanol) extraction pulls out terpenes and other fat-soluble compounds. Dual-extraction products, which use both methods, capture a broader range of active compounds. A capsule of raw dried mushroom powder delivers far less bioavailable material than an extracted product, regardless of what the label says about milligrams per serving.

Second, the supplement industry for medicinal mushrooms is loosely regulated in most countries. Independent testing has repeatedly shown that some products contain little of the advertised species, are bulked with grain filler from the growing substrate, or contain contaminants. If you do choose a supplement, look for products that report beta-glucan content (a reasonable proxy for polysaccharide concentration) and have been tested by a third-party lab.

Third, if you have existing liver disease, are a regular alcohol drinker, or take medications metabolized by the liver, talk to your doctor before adding mushroom supplements. The reishi hepatotoxicity reports are a reminder that “natural” does not mean “safe for everyone,” and that liver-protective compounds in isolation can behave unpredictably in the context of a compromised liver or interactions with other substances.

Eating Mushrooms Versus Taking Supplements

Most of the research discussed here used concentrated extracts or isolated compounds at doses you would not get from a normal diet. But that does not make dietary mushrooms irrelevant. Regular consumption of common culinary mushrooms like shiitake, oyster, and maitake delivers ergothioneine, beta-glucans, and other bioactive compounds in modest but consistent amounts. The lipid-lowering effects seen with shiitake and oyster mushrooms in animal studies used dietary concentrations that, while higher than casual eating, were not dramatically so.

There is a reasonable argument that the best mushroom strategy for liver health is simply eating a variety of mushrooms regularly as part of a balanced diet, rather than chasing high-dose supplements of a single species. You get a broader range of compounds, avoid the risks of concentrated extracts, and sidestep the quality-control issues of the supplement market. The trade-off is that the effects, if they exist in humans, will be gradual and hard to measure. For someone looking for dramatic intervention in active liver disease, dietary mushrooms alone are unlikely to be sufficient. For someone interested in long-term metabolic health and modest liver support, they are a low-risk, evidence-informed choice.